Boehringer Ingelheim announces appointment of Gagandeep Singh as Managing Director and Head of Human Pharma for India
Boehringer Ingelheim announces appointment of Gagandeep Singh as Managing Director and Head of Human Pharma for India
Search
Boehringer Ingelheim expands animal health portfolio in India with the launch of NexGard® (afoxolaner) Small and Medium
Boehringer Ingelheim expands animal health portfolio in India with the launch of NexGard® (afoxolaner) Small and Medium
BI India joins forces with PPAM and BMC to Stop Rabies
This initiative will adopt a two-pronged approach of vaccination and education.
Boehringer Ingelheim India recognized as Top Employer 2024
Boehringer Ingelheim India recognized as Top Employer 2024
Chronic Kidney Disease
Chronic kidney disease affects approximately 850 million people worldwide which is more than ten percent of the population.
About Chronic Kidney Disease
Find out more about chronic kidney disease, it’s causes and symptoms
Jardiance® (empagliflozin) now approved in India for treatment of chronic kidney disease
Jardiance® (empagliflozin) now approved in India
Our Purpose
Find out what 'transforming lives' and 'for generations' means for our work and long-term thinking here. Click here to learn more about our purpose.
We are independent, family-owned
At Boehringer Ingelheim we are independent, family-owned and intend to remain so. Click here to discover how we live our Leitbild and learn more.
A Unique Bond: human and animal health
At Boehringer Ingelheim we are dedicated to animal and human health. We celebrate the truly unique bonds between people and their pets. Learn more here.
Press Releases
Click here to find the latest press releases from Boehringer Ingelheim on animal health, prescription medicine, pipeline and corporate news.
Driving Innovation through Diversity & Inclusion
Inclusive leaders and an inclusive organisation allow diversity to flourish. Diversity is the mix. Inclusion is making the mix work. Learn more here.
Winfrieds Story
Over 60 million people worldwide are affected by heart failure. Listen to Winfried, who has heart failure, speak about the impact of his heartbeat moment.
Poultry
We are proud to play a critical role in feeding the world with safe, affordable, abundant and sustainable quality poultry meat and eggs. Learn more here.
Diabetes
About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95 percent of all cases. Learn more here.
Human Health
Boehringer Ingelheim is dedicated to the discovery, development, manufacture and marketing of innovative health care products. Click here to learn more.
Metabolic Diseases
Interconnected cardio-renal-metabolic conditions – affecting the heart, kidneys, and metabolic system – are the leading cause of mortality worldwide.
Boehringer Ingelheim India and Vvaan Lifesciences Pvt Ltd announce strategic distribution partnership to expand pet portfolio reach.
Boehringer Ingelheim India and Vvaan Lifesciences Pvt Ltd announce strategic distribution partnership to expand pet portfolio reach.
About Us
Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Click here to learn and find out more about us.
Accessibility Statement
Boehringer Ingelheim prides itself on being accessible to our audience. Click here to see how we are making our website as user friendly as possible.
Our Responsibility
Our responsibility here at Boehringer Ingelheim to our patients is by serving people through research into diseases with unmet needs. Learn more here.
Our Stories
Boehringer Ingelheim has many initiatives we would like to share. Find out more about us here by reading our press releases, news stories, and more.
Terms of Use
Click here to read the terms of use on which you may make use of the website www.boehringer-ingelheim.com/in, whether as a visitor or a registered user.
More Potential
Continuing a journey that began more than 135 years ago, Boehringer Ingelheim steps up its commitment to sustainable development. Find out more here.